These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22107829)

  • 1. Ets-1 activates overexpression of JunB and CD30 in Hodgkin's lymphoma and anaplastic large-cell lymphoma.
    Watanabe M; Itoh K; Togano T; Kadin ME; Watanabe T; Higashihara M; Horie R
    Am J Pathol; 2012 Feb; 180(2):831-8. PubMed ID: 22107829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
    Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
    Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma.
    Watanabe M; Ogawa Y; Itoh K; Koiwa T; Kadin ME; Watanabe T; Okayasu I; Higashihara M; Horie R
    Lab Invest; 2008 Jan; 88(1):48-57. PubMed ID: 17965727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
    Hsu FY; Johnston PB; Burke KA; Zhao Y
    Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling.
    Staber PB; Vesely P; Haq N; Ott RG; Funato K; Bambach I; Fuchs C; Schauer S; Linkesch W; Hrzenjak A; Dirks WG; Sexl V; Bergler H; Kadin ME; Sternberg DW; Kenner L; Hoefler G
    Blood; 2007 Nov; 110(9):3374-83. PubMed ID: 17690253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma.
    Atsaves V; Lekakis L; Drakos E; Leventaki V; Ghaderi M; Baltatzis GE; Chioureas D; Jones D; Feretzaki M; Liakou C; Panayiotidis P; Gorgoulis V; Patsouris E; Medeiros LJ; Claret FX; Rassidakis GZ
    Br J Haematol; 2014 Nov; 167(4):514-23. PubMed ID: 25145835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein.
    Pearson JD; Mohammed Z; Bacani JT; Lai R; Ingham RJ
    BMC Cancer; 2012 Jun; 12():229. PubMed ID: 22681779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma.
    Pearson JD; Lee JK; Bacani JT; Lai R; Ingham RJ
    Int J Clin Exp Pathol; 2011 Jan; 4(2):124-33. PubMed ID: 21326808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NPM-ALK oncoprotein abrogates CD30 signaling and constitutive NF-kappaB activation in anaplastic large cell lymphoma.
    Horie R; Watanabe M; Ishida T; Koiwa T; Aizawa S; Itoh K; Higashihara M; Kadin ME; Watanabe T
    Cancer Cell; 2004 Apr; 5(4):353-64. PubMed ID: 15093542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma.
    Yamamoto R; Nishikori M; Tashima M; Sakai T; Ichinohe T; Takaori-Kondo A; Ohmori K; Uchiyama T
    Cancer Sci; 2009 Nov; 100(11):2093-100. PubMed ID: 19703193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G
    Zhang J; Wu Z; Savin A; Yang M; Hsu YR; Jantuan E; Bacani JTC; Ingham RJ
    Sci Rep; 2018 Oct; 8(1):16019. PubMed ID: 30375407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation.
    Hübinger G; Scheffrahn I; Müller E; Bai R; Duyster J; Morris SW; Schrezenmeier H; Bergmann L
    Exp Hematol; 1999 Dec; 27(12):1796-805. PubMed ID: 10641597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal activator protein 1 transcription factor expression in CD30-positive cutaneous large-cell lymphomas.
    Mao X; Orchard G; Russell-Jones R; Whittaker S
    Br J Dermatol; 2007 Nov; 157(5):914-21. PubMed ID: 17725669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive control of AKT1 gene expression by JUNB/CJUN in ALK+ anaplastic large-cell lymphoma: a novel crosstalk mechanism.
    Atsaves V; Zhang R; Ruder D; Pan Y; Leventaki V; Rassidakis GZ; Claret FX
    Leukemia; 2015 Nov; 29(11):2162-72. PubMed ID: 25987255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30 Induces Heat Shock Protein 90 and Signal Integration in Classic Hodgkin Lymphoma Cells.
    Watanabe M; Nakano K; Kadin ME; Higashihara M; Watanabe T; Horie R
    Am J Pathol; 2017 Jan; 187(1):163-175. PubMed ID: 27870927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crizotinib enhances anti-CD30-LDM induced antitumor efficacy in NPM-ALK positive anaplastic large cell lymphoma.
    Wang R; Li L; Duan A; Li Y; Liu X; Miao Q; Gong J; Zhen Y
    Cancer Lett; 2019 Apr; 448():84-93. PubMed ID: 30742941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
    Wellmann A; Otsuki T; Vogelbruch M; Clark HM; Jaffe ES; Raffeld M
    Blood; 1995 Sep; 86(6):2321-8. PubMed ID: 7662979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis.
    Rassidakis GZ; Thomaides A; Atwell C; Ford R; Jones D; Claret FX; Medeiros LJ
    Mod Pathol; 2005 Oct; 18(10):1365-70. PubMed ID: 15920551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.
    Watanabe M; Ogawa Y; Ito K; Higashihara M; Kadin ME; Abraham LJ; Watanabe T; Horie R
    Am J Pathol; 2003 Aug; 163(2):633-41. PubMed ID: 12875982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
    Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
    Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.